Clarigent Health, a mental health technology company, launched Clairity, an app-based listening tool designed to provide clinical decision making support to mental health professionals.
XtalPi, an Artificial Intelligence (AI) drug discovery and development technology company, announced today an oversubscribed Series C funding round of $318.8 million
Movendo Technology, which develops robotics for rehabilitation, has launched the Silver Index, an AI-based algorithm that helps to predict the risk of falls for senior citizens
Cerevel Therapeutics, specialising in neurological disorders, and Cyclica, an AI drug discovery company, are collaborating to accelerate the research and discovery of novel mediciines for neuro diseases
iCAD has launched ProFound AI Risk to provide accurate two-year, breast cancer risk evaluation, based only on a screening mammogram
Deep Longevity launches out of Insilico Medicine to transform research into longevity
inHEART, a medical imaging solution provider for cardiac interventions, has closed a round of €3.7 million led by Elaia
Cost pressures in US healthcare exacerbated by COVID-19 have accelerated adoption of tech to better serve patients and improve margins.
Huma is the new name for Medopad as it makes acquisitions in its quest to make preventative healthcare a reality.
Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors. The funds will be invested to continue building Recursion’s AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology. Recursion […]